Bispezifische Antikörper

European patent · EP2552481 · In force

Register entry

Publication number
EP2552481
Application number
EP11711313
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 24, 2011
Published
Feb 6, 2013
Granted
Feb 22, 2017
Protection ends at the latest
Mar 23, 2031
Next annual fee due
Mar 31, 2027
IPC classes
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
C07K 16/22 (2006.01)
C07K 16/28 (2006.01)
C07K 16/46 (2006.01)
Priority
EP 10003270 26.03.2010
PCT application
PCT/EP2011/054505 24.03.2011
PCT publication
WO2011/117330 29.09.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  5. Oct 19, 2021

    Address changed

    Owner
    Roche Glycart AG, Wagistrasse 18, 8952 Schlieren → Roche Glycart AG, Wagistrasse 10, 8952 Schlieren

    Published in Swissreg on 19.10.2021

  6. Feb 22, 2017

    Granted

    Published in Swissreg on 22.02.2017

Parties

Holder

Roche Glycart AG

Wagistrasse 10, 8952 Schlieren

Inventor

BRINKMANN, Ulrich

82362 Weilheim, DE

CROASDALE-WOOD, Rebecca

PR3 3AX Lancashire, GB

DUERR, Harald

82319 Starnberg, DE

KLEIN, Christian

8906 Bonstetten

KOPETZKI, Erhard

82377 Penzberg, DE

LAU, Wilma

83670 Bad Heibrunn, DE

REGULA, Joerg, Thomas

81377 München, DE

SCHANZER, Juergen, Michael

81667 Muenchen, DE

UMANA, Pablo

8832 Wollerau

WARTHA, Katharina

4054 Basel

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.